Rolziracetam

Chemical compound
  • none
Legal statusLegal status
  • AU: S4 (Prescription only)
  • US: Unscheduled
Identifiers
  • dihydro-1H-pyrrolizine-3,5(2H,6H)-dione
CAS Number
  • 18356-28-0 ☒N
PubChem CID
  • 71893
ChemSpider
  • 64906 checkY
UNII
  • RES9I0LGG5
ChEMBL
  • ChEMBL51396 checkY
CompTox Dashboard (EPA)
  • DTXSID80171444 Edit this at Wikidata
Chemical and physical dataFormulaC7H9N2O2Molar mass153.161 g·mol−13D model (JSmol)
  • Interactive image
  • O=C2N1C(=O)CCC1CC2
InChI
  • InChI=1S/C7H9NO2/c9-6-3-1-5-2-4-7(10)8(5)6/h5H,1-4H2 checkY
  • Key:IEZDOKQWPWZVQF-UHFFFAOYSA-N checkY
 ☒NcheckY (what is this?)  (verify)

Rolziracetam is a nootropic drug of the racetam family.

Rolziracetam was found to improve performance on a delayed-response task in aged rhesus monkeys. It has a wide margin of safety in animals and has been evaluated for use in cognitively impaired human subjects.[1]

See also

  • Piracetam

References

  1. ^ Butler DE, Leonard JD, Caprathe BW, L'Italien YJ, Pavia MR, Hershenson FM, Poschel PH, Marriott JG (March 1987). "Amnesia-reversal activity of a series of cyclic imides". Journal of Medicinal Chemistry. 30 (3): 498–503. doi:10.1021/jm00386a010. PMID 3820221.


Stub icon

This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.

  • v
  • t
  • e